Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-21-000285
Filing Date
2021-01-12
Accepted
2021-01-12 17:19:44
Documents
23

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 2957791
2 filename2.htm EX-10.13 181628
3 filename3.htm EX-10.27 39071
4 GRAPHIC g55959g01a20.jpg GRAPHIC 170359
5 GRAPHIC g55959g01n81.jpg GRAPHIC 121391
6 GRAPHIC g55959g01o26.jpg GRAPHIC 49175
7 GRAPHIC g55959g02v15.jpg GRAPHIC 80784
8 GRAPHIC g55959g03b88.jpg GRAPHIC 46850
9 GRAPHIC g55959g05v59.jpg GRAPHIC 96180
10 GRAPHIC g55959g07a10.jpg GRAPHIC 121648
11 GRAPHIC g55959g07p85.jpg GRAPHIC 162676
12 GRAPHIC g55959g08b20.jpg GRAPHIC 153453
13 GRAPHIC g55959g11i11.jpg GRAPHIC 120296
14 GRAPHIC g55959g11i52.jpg GRAPHIC 93601
15 GRAPHIC g55959g12y55.jpg GRAPHIC 143065
16 GRAPHIC g55959g13v79.jpg GRAPHIC 66147
17 GRAPHIC g55959g14y66.jpg GRAPHIC 58763
18 GRAPHIC g55959g15a65.jpg GRAPHIC 55728
19 GRAPHIC g55959g20k44.jpg GRAPHIC 71491
20 GRAPHIC g55959g22i22.jpg GRAPHIC 144662
21 GRAPHIC g55959g62p11.jpg GRAPHIC 65604
22 GRAPHIC g55959g69f14.jpg GRAPHIC 59591
23 GRAPHIC g55959g97j23.jpg GRAPHIC 37553
  Complete submission text file 0000950123-21-000285.txt   5805199
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Filer) CIK: 0001656536 (see all company filings)

EIN.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-03877 | Film No.: 21524255
SIC: 2834 Pharmaceutical Preparations